U.S. Attorney’s Office Announces Settlement with Chicago Pharmacy for Alleged Violations of the Controlled Substances Act

CHICAGO - The U.S. Attorney's Office today announced a civil settlement with a Chicago pharmacy to resolve alleged violations of the Controlled Substances Act.

The alleged violations by Allcare Discount Pharmacy in Chicago's Logan Square neighborhood enabled the diversion of opioids from the pharmacy over an extended period. An inspection and audit by the U.S. Drug Enforcement Administration found that Allcare failed to keep adequate records pertaining to the receipt and disposition of various controlled substances, including hydrocodone-acetaminophen and alprazolam. The DEA determined that Allcare also failed to provide effective controls and procedures to prevent theft and diversion of controlled substances.

From 2015 to 2017, two Allcare pharmacy techs conspired to steal more than 56,000 pills of hydrocodone and sell them outside the pharmacy. One of the techs concealed the theft by falsifying the pharmacy's inventory to make it look like the pills had either not been received from the distributor or had been dispensed to patients. The techs pleaded guilty to federal drug charges and were sentenced in 2019 to prison terms of five years and one year.

Under the terms of the civil settlement, Allcare will pay a $250,000 penalty to the United States. Allcare also successfully fulfilled its obligations under a Memorandum of Agreement with the DEA that required the pharmacy to maintain complete and accurate records pertaining to the receipt and sale of controlled substances. The settlement is not an admission of liability by Allcare, nor a concession by the United States that its potential claims were not well-founded.

The settlement was announced by Andrew S. Boutros, United States Attorney for the Northern District of Illinois, and Shane Catone, Special Agent-in-Charge of the DEA Chicago Field Division. The civil case was handled by Assistant U.S. Attorney Valerie R. Raedy and the Affirmative Civil Enforcement (ACE) Unit of the U.S. Attorney's Office.

"Pharmacies must take their responsibilities under the Controlled Substances Act seriously and comply with security protocols and proper oversight to prevent diversion of controlled substances," said U.S. Attorney Boutros. "The Chicago U.S. Attorney's Office will continue to work closely with our law enforcement partners to enforce full compliance with the Controlled Substances Act and protect our communities from the dangers of opioid diversion and abuse."